Suppr超能文献

鉴定对哇巴因结合至关重要的羊肾(钠,钾)-ATP酶中的半胱氨酸残基。

Identification of cysteine residues in lamb kidney (Na,K)-ATPase essential for ouabain binding.

作者信息

Kirley T L, Peng M

机构信息

Department of Pharmacology and Biophysics, University of Cincinnati College of Medicine, Ohio 45267-0575.

出版信息

J Biol Chem. 1991 Oct 25;266(30):19953-7.

PMID:1657908
Abstract

N-(1-Pyrene)maleimide is a hydrophobic, sulfhydryl-directed, chemical modification probe which, at a low concentration, inhibits the capacity of lamb kidney sodium- and potassium-activated adenosine triphosphatase [Na,K)-ATPase; EC 3.6.1.3) to bind ouabain. This inhibition is partially blocked by preincubation of the enzyme with ouabagenin, an aglycone derivative which can be used as a reversible protecting ligand for the ouabain binding site. The kinetics of inhibition are not first order, suggesting that there may be more than one site of labeling which is responsible for the inhibition of ouabain binding. Although earlier work (Kirley, T. L., Lane, L. K., and Wallick, E. T. (1986) J. Biol. Chem. 261, 4525-4528) indicates that the inhibition is accompanied by a loss in the number of binding sites rather than a decrease in affinity of the sites for the ligand, other data (Scheiner-Bobis, G., Zimmerman, M., Kirch, V., and Schoner, W. (1987) Eur. J. Biochem. 165, 653-656) indicates that there is no cysteine residue located extracellularly in the ouabain binding site. By sequence analysis of alpha subunit peptides labeled by N-(1-pyrene)maleimide in the absence but not in the presence of protecting ligand, it is demonstrated in this work that there are two major sites of labeling protected by the binding of ouabagenin, Cys-367 and Cys-656. Both of these sites are located in the large cytoplasmic domain of the alpha subunit, one close to the phosphorylation site (Asp-369), and the other implicated in the binding of ATP (Cys-656). Therefore, it appears from this data that the inhibition of ouabain binding by N-(1-pyrene)maleimide is not due to modification of a site in the binding pocket for cardiac glycosides, but rather to an allosteric effect, since cardiac glycoside binding is known to be dependent on the phosphorylation state of the enzyme. The dependence of inhibition on the presence of sodium, potassium, and ATP also is consistent with this interpretation. The work reported here thus explains the apparent paradox posed by the earlier data.

摘要

N-(1-芘基)马来酰亚胺是一种疏水性、巯基导向的化学修饰探针,在低浓度下,它会抑制羊肾钠钾激活的三磷酸腺苷酶[Na,K)-ATP酶;EC 3.6.1.3]与哇巴因结合的能力。用哇巴因配基(一种糖苷配基衍生物,可作为哇巴因结合位点的可逆保护配体)对该酶进行预孵育,可部分阻断这种抑制作用。抑制动力学不是一级反应,这表明可能有多个标记位点导致了对哇巴因结合的抑制。尽管早期的研究(Kirley, T. L., Lane, L. K., and Wallick, E. T. (1986) J. Biol. Chem. 261, 4525-4528)表明这种抑制伴随着结合位点数量的减少而非位点对配体亲和力的降低,但其他数据(Scheiner-Bobis, G., Zimmerman, M., Kirch, V., and Schoner, W. (1987) Eur. J. Biochem. 165, 653-656)表明在哇巴因结合位点的细胞外没有半胱氨酸残基。通过对在不存在但存在保护配体时被N-(1-芘基)马来酰亚胺标记的α亚基肽段进行序列分析,本研究证明有两个主要的标记位点受哇巴因配基结合的保护,即Cys-367和Cys-656。这两个位点都位于α亚基的大细胞质结构域中,一个靠近磷酸化位点(Asp-369),另一个与ATP的结合有关(Cys-656)。因此,从这些数据来看,N-(1-芘基)马来酰亚胺对哇巴因结合的抑制并非由于对强心苷结合口袋中位点的修饰,而是由于变构效应,因为已知强心苷结合依赖于该酶的磷酸化状态。抑制对钠、钾和ATP存在的依赖性也与这种解释一致。因此,这里报道的工作解释了早期数据所带来的明显矛盾。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验